On 22 August 2022, ECHA started a 60 day public commenting period on the Harmonised Classification and Labelling (CLH) proposals for the following substance:
CLH consultation launched on Penconazole
Previous
Previous
2-tert-butyl-4-methoxyphenol added to Endocrine Disruptor Assessment List
Next
Next
